BioSpace News Archive

Drug Development

Foamix Announces Positive Topline Results from Third Phase 3 Trial (Study FX2017-22) Evaluating FMX101 Topical Minocycline Foam for Moderate-to-Severe Acne

FMX101 Demonstrated Highly Statistically Significant Improvement Compared with Vehicle in Both Co-Primary Efficacy Endpoints

September 12, 2018
·
7 min read
Business

Arix Bioscience plc: Changes announced to executive team to accelerate growth and strategy

Changes announced to executive team to accelerate growth and strategy

September 12, 2018
·
3 min read
Plasticell wins military contract to develop regenerative medicines for the battlefield.

Plasticell Ltd has announced that it has been contracted by the Ministry of Defence (MoD) in a pilot programme to develop regenerative medicines for the treatment of injuries resulting from combat or terrorism.

September 12, 2018
·
2 min read
Policy

Recro Pharma Provides Regulatory Update for IV Meloxicam

Company Anticipates NDA Resubmission by the End of September 2018

September 12, 2018
·
6 min read
Business

Merck & IRBM announce pioneering collaboration to advance peptide therapeutics

IRBM signs collaboration agreement with Merck & Co., Inc, Kenilworth, NJ, USA to advance peptide therapeutics

September 12, 2018
·
2 min read
Clinithink receives RARE Champion of Hope award for their ‘notable efforts’ in rare disease

Clinithink has been selected to receive the RARE Champion of Hope – Collaborations in Science and Technology award at the 7th Annual RARE Patient Advocacy Summit on October 4th in Irvine, California.

September 12, 2018
·
2 min read
DEP® irinotecan outperforms in pancreatic cancer model

DEP® irinotecan outperforms in pancreatic cancer model

September 12, 2018
·
7 min read
Business

Adaptimmune Therapeutics plc Announces Registered Direct Offering of American Depositary Shares

Adaptimmune Therapeutics plc today announced that it has entered into a definitive agreement with Matrix Capital Management Company

September 12, 2018
·
5 min read
NHS England announces groundbreaking new personalised therapy for children with cancer

NHS patients to benefit from Europe’s first full access deal on breakthrough CAR-T therapy.

September 12, 2018
·
3 min read
Business

CURE Pharmaceutical Expands Distribution of CUREfilm Technology with First Licensing Agreement

CURE grants cannabis leader rights to its proprietary drug delivery technology in markets around the world

September 12, 2018
·
3 min read